Abstract:The NF-κB (nuclear factor κ-light-chain-enhancer of activated B cells) transcription factor family is a pleiotropic regulator of many cellular signaling pathways, providing a mechanism for the cells in response to a wide variety of stimuli linking to inflammation. The stimulated cells will be regulated by not only the canonical but also non-canonical NF-κB pathways. To initiate both of these pathways, IκB-degradation triggers NF-κB release and the nuclear translocated-heterodimer (or homodimer) can associate with the κB sites of promoter to regulate the gene transcriptions. NF-κB ubiquitously expresses in neurons and the constitutive NF-κB activation is associated with processing of neuronal information. NF-κB can regulate the transcription of genes such as chemokines, cytokines, proinflammatory enzymes, adhesion molecules, proinflammatory transcription factors, and other factors to modulate the neuronal survival. In neuronal insult, NF-κB constitutively active in neuron cell bodies can protect neurons against different injuries and regulate the neuronal inflammatory reactions. Besides neurons, NF-κB transcription factors are abundant in glial cells and cerebral blood vessels and the diverse functions of NF-κB also regulate the inflammatory reaction around the neuronal environment. NF-κB transcription factors are abundant in the brain and exhibit diverse functions. Several central nerve system (CNS) diseases are linked to NF-κB activated by inflammatory mediators. The RelA and c-Rel expression produce opposite effects on neuronal survival. Importantly, c-Rel expression in CNS plays a critical role in anti-apoptosis and reduces the age-related behaviors. Moreover, the different subunits of NF-κB dimer formation can modulate the neuroninflammation, neuronal protection, or neurotoxicity. The diverse functions of NF-κB depend on the subunits of the NF-κB dimer-formation which enable us to develop a therapeutic approach to neuroinflammation based on a new concept of inflammation as a strategic tool in neuronal cells. However, the detail role of NF-κB in neuroinflammation, remains to be clarified. In the present article, we provide an updated review of the current state of our knowledge about relationship between NF-κB and neuroinflammation.

The noncanonical NFκB pathway: Regulatory mechanisms in health and disease

Noncanonical NF-κB Pathway Controls the Production of Type I Interferons in Antiviral Innate Immunity

The non-canonical NF-κB pathway in immunity and inflammation

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study

NF‐κB signaling in inflammation and cancer

Role and Mechanisms of the NF-ĸB Signaling Pathway in Various Developmental Processes

Progress and Prospects of Non-Canonical NF-κB Signaling Pathway in the Regulation of Liver Diseases

Not just for lymphoid cells: The role of the noncanonical NF-κB signaling pathway in early and late myelopoiesis with a focus on hypereosinophilic disorders

Signaling via the NFκB system

Inflammation-Induced Tumorigenesis: Diminished Noncanonical NF-κB Signaling is Associated with Pathogenesis of Colitis-associated Colorectal Cancer

The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases

NF-κB in biology and targeted therapy: new insights and translational implications

NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review

NF-κB signaling in inflammation

Non-canonical NF-κB signaling limits the tolerogenic β-catenin-Raldh2 axis in gut dendritic cells to exacerbate intestinal pathologies

NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration

NF-κB: At the Borders of Autoimmunity and Inflammation

Nrf2 Signaling Pathway: Pivotal Roles in Inflammation.

NF-kappa B Inducing Kinase Regulates Intestinal Immunity and Homeostasis

Focus on negatively regulated NLRs in inflammation and cancer

A NIK-SIX Signalling Axis Controls Inflammation by Targeted Silencing of Non-Canonical NF-κB.